BRAUNS; Ulrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for BRAUNS; Ulrich.The latest application filed is for "administration of ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- l-1h-benzimidazol-5-carbonyl)".

Company Profile

2.3.13

BRAUNS; Ulrich - Biberach an der Riss DE
Brauns; Ulrich - Biberach DE
Brauns; Ulrich - Kiel DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Administration Of Ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- L-1h-benzimidazol-5-carbonyl) App 20200085807 - BRAUNS; Ulrich ; et al.	2020-03-19
Administration Of Ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- L-1h-benzimidazol-5-carbonyl) App 20190231766 - BRAUNS; Ulrich ; et al.	2019-08-01
Administration Of Ethyl 3-[(2-{[4-(hexyloxycarbonyl-aminoiminomethyl)phenyl-amino]methyl}-1-methy- L-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionate App 20180221359 - BRAUNS; Ulrich ; et al.	2018-08-09
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonyl-amino-imino-methyl)-phenylamino]-methyl}-1-me- thyl-1 H-benzimidazol acid ethyl ester and the salts thereof Grant 9,925,174 - Brauns March 27, 2	2018-03-27
Administration Of Ethyl 3-[(2--1-methyl-1h-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionate App 20150005350 - BRAUNS; Ulrich ; et al.	2015-01-01
Solid Pharmaceutical Preparation App 20100178342 - Brauns; Ulrich ; et al.	2010-07-15
Administration Form For The Oral Application Of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-met- Hyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic Acid Ethyl Ester And The Salts Thereof App 20060183779 - Brauns; Ulrich ; et al.	2006-08-17
Pharmaceutical compositions for the treatment of female sexual disorders App 20060025420 - Brauns; Ulrich ; et al.	2006-02-02
Pharmaceutical formulation containing an LTB4-antagonist, as well as processes for the preparation thereof and the use thereof App 20050129768 - Bock, Thomas ; et al.	2005-06-16
Solid pharmaceutical preparation App 20050124651 - Brauns, Ulrich ; et al.	2005-06-09
Administration form for the oral application of poorly soluble drugs App 20050095293 - Brauns, Ulrich ; et al.	2005-05-05
Administration form for the oral application of poorly soluble acidic and amphorteric drugs App 20050053669 - Friedl, Thomas ; et al.	2005-03-10
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbony- lamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbo- nyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof App 20030181488 - Brauns, Ulrich	2003-09-25
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation Grant 6,407,079 - Muller , et al. June 18, 2	2002-06-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.